Recruiting |
Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias
|
Recruiting |
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
- Conditions: Cardiogenic Shock, Mitral Regurgitation
|
Recruiting |
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
|
Recruiting |
An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac Rehabilitation
|
Recruiting |
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
- Conditions: Cardiac Allograft Vasculopathy, Heart Transplant
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
- Conditions: Atrial Fibrillation, Persistent Atrial Fibrillation
|
Recruiting |
Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT)
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Novartis, Servier, AstraZeneca
|
Recruiting |
A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery
|
Recruiting |
REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial
- Conditions: Mitral Valve Insufficiency, Coronary Artery Disease
|
Recruiting |
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
- Conditions: Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation
- Interventions: Procedure MitraClip TMVR and Watchman LAAO
|
Recruiting |
Bentracimab (PB2452) in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure
- Conditions: Hemorrhage, Urgent Surgery, Invasive Procedure
- Interventions: Drug Bentracimab (PB2452) Infusion
|
Recruiting |
Exercise Training in Women With Heart Disease
- Conditions: Cardiovascular Diseases, Coronary Heart Disease
- Interventions: Behavioral Exercise
|
Recruiting |
Amplatzer Amulet LAAO vs. NOAC
- Conditions: Atrial Fibrillation, Stroke, Bleeding
|
Recruiting |
Surgical PA-LAA Shunting: a Feasibility Study
- Interventions: Procedure PA-LAA shunt
|
Recruiting |
MitraClip REPAIR MR Study
|
Recruiting |
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
- Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency, Cardiovascular Diseases, Valve Disease, Heart, Heart Valve Diseases, Functional Mitral Regurgitation, Degenerative Mitral Valve Disease
|
Recruiting |
The COVID-RASi Trial (COVID-19)
- Conditions: COVID-19, Cardiovascular Diseases
|
Recruiting |
Barrier-Protect Study
- Interventions: Other Barrier dressing
|
Recruiting |
Evaluating Auscul-X, a Touch Free Digital Stethoscope
- Interventions: Device Auscul-X
- Sponsor: AusculSciences Canada Inc., Ottawa Heart Institute Research Corporation
|
Recruiting |
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
- Conditions: Dilated Cardiomyopathy, Lamin A/C Gene Mutation
|
Recruiting |
Randomization of Single vs Multiple Arterial Grafts
- Conditions: Coronary Artery Disease, Heart Diseases
- Sponsor: Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Cytisine Compared to Combination NRT in Relapsed Smokers
- Conditions: Smoking Cessation, Coronary Artery Disease
|
Recruiting |
Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, GE Healthcare
|
Recruiting |
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
|
Recruiting |
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Conditions: Atrial Fibrillation, Stroke, Bleeding
- Sponsor: Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University Medical Center
|
Recruiting |
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
|
Recruiting |
TRILUMINATE Pivotal Trial
- Interventions: Device Tricuspid valve repair
|
Recruiting |
Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation
- Interventions: Drug Sildenafil Citrate
- Sponsor: University of Calgary, Pfizer
|
Recruiting |
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- Conditions: Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
- Interventions: Procedure Thoracic Aortic Surgery
- Sponsor: Ottawa Heart Institute Research Corporation, University of Calgary
|
Recruiting |
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
- Conditions: Heart Transplant Failure and Rejection, Heart Failure, Heart Diseases, Heart Failure,Congestive, Transplant, Failure, Heart, Transplant Failure
- Interventions:
- Sponsor: University of British Columbia, Canadian Institutes of Health Research (CIHR), PROOF Centre of Excellence, Duke University, University of Nebraska, Toronto General Hospital, St. Paul's Hospital, Canada
|
Recruiting |
Smartphone Assessment Prior Radial Artery Harvesting for CABG
|
Recruiting |
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
- Conditions: Cardiovascular Diseases, Atherosclerosis, Inflammation, Diabetes
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms
- Conditions: Atrial Fibrillation, Type 2 Diabetes
- Interventions: Behavioral High-intensity interval training + standard care
|
Recruiting |
Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health Outcomes
- Interventions: Other Healing Hearts Together
|
Recruiting |
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus
|
Recruiting |
Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD
- Interventions: Behavioral HY-PAD
- Sponsor: Ottawa Heart Institute Research Corporation, AFP Innovation Fund
|
Recruiting |
Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation (Exercise-AF)
- Conditions:Persistent or Permanent Atrial Fibrillation (Exercise-AF)
- Interventions:Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.
Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.
|
Recruiting |
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- Interventions: Drug Rivaroxaban 15 MG Oral Tablet [Xarelto]
|
Recruiting |
Cardiac Sarcoidosis Randomized Trial
- Conditions: Cardiac Sarcoidosis, Sarcoidosis
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- Sponsor: Ottawa Heart Institute Research Corporation, London Health Sciences Centre, Heart Center Leipzig - University Hospital, Fortis Escorts Heart Institute, The Methodist Hospital Research Institute, Carolinas Medical Center, Gundersen Lutheran Health System, Jilin Heart Hospital, Far Eastern Memorial Hospital, Medtronic, Apollo Hospitals Enterprise Limited, Fresno Heart and Surgical Hospital, Ichinomiya-Nishi Hospital
|
Recruiting |
Peer Support for Women With Heart Disease: Women@Heart
- Conditions: Coronary Heart Disease, Women's Health
- Interventions: Behavioral Women@Heart Program
|
Recruiting |
Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation
|
Recruiting |
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
- Interventions: Procedure Catheter ablation
- Sponsor: Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
|
Recruiting |
Spironolactone Therapy in Chronic Stable Right HF Trial
- Conditions: Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2, Pulmonary Hypertension, Primary, 3, Pulmonary Hypertension, Primary, 4, Cardiomyopathy Right Ventricular
|
Recruiting |
Biomarker Guided Discharge of Heart Failure Patients
- Interventions: Other Biomarker guided discharge algorithm
- Sponsor: Peter Liu, Genome Canada, Roche Diagnostics, Ottawa Heart Institute Research Corporation
|
Recruiting |
Sub-Clinical Atrial Fibrillation Biomarker Study
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Population Health Research Institute, Genome Canada, Bristol-Myers Squibb, Pfizer, Medtronic, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
- Sponsor: Northern Therapeutics, Ottawa Hospital Research Institute
|
Recruiting |
Personalized Dosing of Nicotine Replacement (NRT to Effect)
- Conditions: Tobacco Use Disorder, Nicotine Dependence
- Sponsor: Centre for Addiction and Mental Health, Canadian Cancer Society (CCS), Ottawa Heart Institute Research Corporation
|
Recruiting |
Comparing Hypothermic Temperatures During Hemiarch Surgery
- Interventions: Procedure Hypothermic circulatory arrest
|
Recruiting |
Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus
- Conditions: Diabetes Mellitus, Coronary Artery Disease
- Interventions: Device Pressure Wire Certus, St. Jude Medical, USA
|
Recruiting |
Mobilization of Endothelial Progenitor Cells and Aspirin
- Interventions: Drug Aspirin
|
Recruiting |
Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training
|
Recruiting |
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
- Interventions: Other single photon emission computed tomography
- Sponsor: Ottawa Heart Institute Research Corporation, GE Healthcare
|
Recruiting |
Cardiac FDG PET Viability Registry
- Conditions: Heart Failure, Ischemic Heart Disease, Myocardial Dysfunction
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Ontario Ministry of Health and Long Term Care
|
Recruiting |
Cardiac Sarcoidosis Multi-Center Prospective Cohort
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Ontario Ministry of Health and Long Term Care, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)
- Sponsor: Laval University, University Hospital, Brest
|
Recruiting |
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
- Conditions: Heart Disease, Congestive Heart Failure, Atrial Fibrillation
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
PERIGON Pivotal Trial
- Interventions: Device Model 400 aortic valve bioprosthesis
- Sponsor: Medtronic Cardiac Surgery, Medtronic
|
Recruiting |
ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.
- Conditions: Heart Failure, Obstructive Sleep Apnea, Central Sleep Apnea
- Interventions: Other [C11]Acetate and HED PET
|
Recruiting |
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
- Conditions: Atrial Fibrillation, Stroke
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
|